Skip to main content
Signal8

BioCorRx Inc. (BICX)

BioCorRx Inc. (BICX), through its various operations, is dedicated to creating and delivering therapeutic solutions for individuals struggling with substance dependence and related health conditions across the United States. Among its core offerings is the BioCorRx recovery program, an innovative, non-addictive treatment model. This program uniquely combines proprietary naltrexone implants with extensive counseling services to support patient recovery. Additionally, the company provides the UnCraveRx weight management program, a medically supported initiative designed to curb food cravings. This program integrates pharmacological assistance with readily available virtual support focusing on lifestyle adjustments, fitness, and nutritional guidance. Looking to the future, BioCorRx is actively advancing its product pipeline. This includes BICX101, an injectable naltrexone product, and BICX104, an implantable naltrexone device, both currently under development for the specific treatment of opioid addiction and alcoholism. The company's programs are made available to patients through a network of healthcare providers, independent licensed clinics, and other qualified healthcare professionals. Originally established as Fresh Start Private Management, Inc., the organization officially rebranded as BioCorRx Inc. in January 2014. Its corporate headquarters are situated in Anaheim, California.

Sector: Services-Specialty Outpatient Facilities, NEC

Industry: Medical - Care Facilities

BioCorRx Inc. logo

BioCorRx Inc.

OTC:BICXHealthcare
+7.73%$0.2255
CLOSED
Mkt Cap$6.91M
EV-
Float2.13M
O/S30.64M
VOL157 sh
$ Vol$35
RVOL0.15×
Inst Own-
Net Cash/Sh-
Dilution
BioCorRx Inc. logoOTC:BICXClosed$0.2255+7.73%

BioCorRx Inc. (BICX) dilution facts from SEC filings

Snapshot as of Sep 30, 2026, built from 10 SEC filings.

Shelf registration
None on file in the filings reviewed
At-the-market (ATM) program
No active program in the filings reviewed
Warrants outstanding
8 warrant series recorded as outstanding
Most recent offering
PIPE, priced May 21, 2026
Source: 10-Q filed Nov 16, 2026

Check another stock for dilution

Facts as recorded in the company's SEC filings. The full snapshot, with instrument terms, share counts and history, is part of Signal8 Pro.

Unlock with Signal8 Pro